In the interest of generating estimates for the overall adult U.S. Two-week weighted period prevalence (%) and 95% CIs were estimated for long COVID among those reporting previous COVID-19. †† Beginning September 14, 2022, participants were asked about significant activity limitation from long COVID (i.e., long-term symptoms significantly reduced ability to carry out day-to-day activities compared with the time before having COVID-19). ¶ Respondents reported previous COVID-19 diagnosis** (i.e., ever tested positive for COVID-19 or were told by a doctor or other health care provider they had COVID-19) and current long COVID via an online survey. Census Bureau Master Address File and included all valid addresses with an associated mobile phone number or an email address. The HPS sampling frame was derived from the U.S. § Long COVID questions were added to the survey beginning June 1, 2022. The HPS is a rapidly deployed, cross-sectional national survey with a 2 weeks on, 2 weeks off collection and dissemination approach designed to measure the social and economic effects of COVID-19 on U.S. Some populations might be at increased risk for long COVID, including those who experience more severe acute SARS-CoV-2 infection.* Adults aged ≥50 years are more likely to have severe COVID-19 than are younger persons † however, the risk for long COVID and significant activity limitation by age is not well characterized.ĬDC analyzed data from the Census Bureau’s Household Pulse Survey (HPS) from June 1–13, 2022 to June 7–19, 2023, with the exception of August 24–Septemand November 30–December 8, 2022, when no data were collected. A study of the 2021–2022 Omicron BA.1/BA.2 wave in Australia found that long COVID was responsible for 74% of the years lived with disability from SARS-CoV-2 infections ( 4). Further, long COVID can have a significant impact on quality of life, functional status, and ability to work ( 3). health systems found that SARS-CoV-2 infection was associated with a 4% increase in health care utilization over the 6 months following a positive SARS-CoV-2 test result ( 2). A retrospective cohort study among eight large integrated U.S. Long COVID places substantial strain on the health care system ( 2). Estimates of long COVID incidence among nonhospitalized adults with COVID-19 range from 7.5% to 41% ( 1).

Long COVID includes a wide range of ongoing respiratory, neurologic, cardiovascular, and other symptoms that can last for weeks, months, or years following SARS-CoV-2 infection. These findings help guide the ongoing COVID-19 prevention efforts and planning for long COVID symptom management and future health care service needs.

During June 7–19, 2023, 26.4% (95% CI = 24.0–28.9) of adults with long COVID reported significant activity limitation, the prevalence of which did not change over time. Among adults reporting previous COVID-19, prevalence decreased among those aged 30–79 years through fall or winter and then stabilized.

When stratified by age, only adults aged <60 years experienced significant rates of decline (p<0.01).

Among both groups, prevalence decreased from June 1–13, 2022, through January 4–16, 2023, before stabilizing. Data from surveys completed between June 1–13, 2022, and June 7–19, 2023, indicated that long COVID prevalence decreased from 7.5% (95% CI = 7.1–7.9) to 6.0% (95% CI = 5.7–6.3) among the overall U.S. CDC analyzed national repeat cross-sectional Household Pulse Survey data to estimate the prevalence of long COVID and significant related activity limitation among U.S. Long COVID is a condition encompassing a wide range of health problems that emerge, persist, or return following COVID-19.

Among us font